Independent and not affiliated with the FDA, MHRA, ISPE, PDA, or any agency. Get the appgoutham@madhadi.com
madhadi.comData Integrity & GxP Quality
Browse all topics → Articles Templates & Procedures Learning paths GlossaryScenariosToolsRegulatory ReferencesLearning PathsTopics About Start here
Log Plug-and-play starting point Clinical & GCP

Log: KRI/QTL Register and Signal Disposition Log

A plug-and-play register of key risk indicators and quality tolerance limits plus a signal disposition log for risk-based clinical monitoring: KRI definitions, thresholds, data source, actions, QTL parameters, and the auditable record of every signal and its outcome, with a filled specimen.

Document type: Log

Read and copy the template below into your own quality system. It is a generic starting point for your own internal use, provided as is, with no warranty; see the Terms and License. Adopting it does not by itself create compliance.

This is a ready-to-use pair of records for central monitoring: a register that defines every key risk indicator (KRI) and quality tolerance limit (QTL), and a signal disposition log that captures what happened each time a threshold was crossed. Together they answer the single most common risk-based monitoring inspection question: you had the data, what did you do about it? Replace every <<FILL: ...>> placeholder and maintain the log continuously. A filled specimen follows. This is general guidance to adapt and verify, not legal or regulatory advice.

Part A: KRI register (definitions)

A KRI is a per-site metric with a threshold and a defined action. Every KRI here must have all columns filled; a KRI without a threshold or an action does not belong in the register.

KRI IDKRI nameWhat it signalsData sourceThreshold logic (green/amber/red)Review cadenceDefined action on red
<<FILL: KRI-01>><<FILL: screen failure rate>><<FILL: eligibility manipulation / recruitment pressure>><<FILL: EDC>><<FILL: vs study mean, > 2 SD>><<FILL: biweekly>><<FILL: central review, corroborate, trigger visit>>
<<FILL: KRI-02>><<FILL: enrollment rate vs plan>><<FILL: recruitment fraud / low engagement>><<FILL: CTMS>><<FILL: outlier vs peers>><<FILL: biweekly>><<FILL: assess eligibility signal>>
<<FILL: KRI-03>><<FILL: query rate / aging>><<FILL: data quality / responsiveness>><<FILL: EDC>><<FILL: aged > X days>><<FILL: weekly>><<FILL: site follow-up>>
<<FILL: KRI-04>><<FILL: data entry lag>><<FILL: contemporaneity / overwhelmed site>><<FILL: EDC>><<FILL: median > X days>><<FILL: biweekly>><<FILL: remote check>>
<<FILL: KRI-05>><<FILL: SAE reporting timeliness>><<FILL: safety reporting compliance>><<FILL: safety database>><<FILL: any late report>><<FILL: continuous>><<FILL: safety escalation>>
<<FILL: KRI-06>><<FILL: AE/SAE rate vs expected>><<FILL: under-reporting or safety signal>><<FILL: EDC>><<FILL: far from pooled rate>><<FILL: biweekly>><<FILL: medical review>>
<<FILL: KRI-07>><<FILL: protocol deviation rate>><<FILL: conduct quality / training gap>><<FILL: deviation log>><<FILL: above peer sites>><<FILL: monthly>><<FILL: retraining / CAPA>>

Part B: QTL register (trial-level)

QTLs are few. A breach is assessed for root cause and impact and may be reported in the clinical study report.

QTL IDParameterLimitRationale (critical-to-quality factor)Escalation and reporting on breach
<<FILL: QTL-01>><<FILL: overall rate of a specific important protocol deviation>><<FILL: e.g. NMT X%>><<FILL>><<FILL: assess root cause/impact; CSR note>>
<<FILL: QTL-02>><<FILL: rate of important eligibility violations>><<FILL>><<FILL>><<FILL>>
<<FILL: QTL-03>><<FILL: rate of incomplete primary endpoint data>><<FILL>><<FILL>><<FILL>>

Keep the QTL count small; a long QTL list usually means site-level KRIs have been mislabeled as trial-level limits.

Part C: Signal disposition log

One row per signal, per site, per review. “Reviewed, no action” is a valid, documented disposition; an undocumented red flag is not.

FieldFormatRequiredWhoWhen
Signal IDText/IDYesSystem / central monitorAt detection
Date detectedDateYesSystemAt detection
SiteSite IDYesSystemAt detection
KRI / QTL / statistical checkReferenceYesCentral monitorAt review
Value vs thresholdTextYesCentral monitorAt review
Assessment (real risk vs artifact; corroborating KRIs)TextYesCentral monitoring meetingAt review
Action chosenTextYesCentral monitoring meetingAt review
Action owner and due dateText/DateYesCentral monitoring meetingAt review
Outcome / closureTextYesOwnerAt closure
Linked query / deviation / CAPAReferenceIf raisedOwnerAt closure

Retention: retain with the trial master file per <<FILL: retention period>>.

Acceptance criteria

  • Every KRI in the register has a data source, a threshold, a cadence, and a defined action.
  • QTLs are few and each has a rationale and an escalation path.
  • Every red signal appears in the disposition log with an assessment, an action (or a documented no-action), and an outcome.
  • No signal in the log is left open past its due date without a recorded reason.

References

ICH E6(R2) Good Clinical Practice, sections 5.0 and 5.18.3; ICH E6(R3) Annex 1. FDA guidance, A Risk-Based Approach to Monitoring of Clinical Investigations (2019) and its Questions and Answers (2023). ICH E8(R1) for critical-to-quality factors underpinning QTLs.

Confirm the current status of each reference before use.


Filled specimen

The following shows one KRI register row and one disposition-log entry for an example study. Illustrative only.

KRI register row: KRI-06, AE/SAE rate vs expected, signals under-reporting or a safety signal, source EDC, red if a site’s per-subject AE rate is below half the pooled rate, reviewed biweekly, action on red is medical review and consider a triggered visit.

Signal disposition log entry:

FieldEntry
Signal IDSIG-2026-0087
Date detected15 June 2026
SiteSite 014
KRI / checkKRI-06 (AE rate 0.4 vs pooled 1.9); corroborated by KRI-01 (screen failure 11% vs 34%) and KRI-02 (enrollment 3x peers)
Value vs thresholdRed on KRI-06; amber/red cluster across three KRIs
AssessmentPattern consistent with eligibility manipulation and AE under-reporting; not an artifact of small n (18 subjects enrolled)
Action chosenTriggered focused on-site visit within 10 business days; targeted SDV of consent, eligibility, and AE source for all enrolled subjects; coordinator interview
Owner and due dateLead CRA; due 29 June 2026
Outcome / closureVisit completed 26 June; 2 eligibility deviations and 4 unreported AEs found; site retrained; CAPA opened
Linked query / deviation / CAPADEV-2026-0233, CAPA-2026-0041

This entry is exactly the audit trail an inspector wants: a signal detected, corroborated, assessed as real, acted on within a defined time, and carried through to a documented outcome and CAPA.

Common inspection findings this log prevents

  • KRIs computed but never acted on, with no disposition record.
  • A red signal handled in email or a personal spreadsheet, so the decision trail cannot be reconstructed.
  • QTLs confused with KRIs, or 40 “QTLs” that are really site metrics.
  • A recurring cross-site signal patched site-by-site with no root cause or CAPA.
  • Signals left open indefinitely with no owner or due date.

How to adapt this log

  1. Populate the KRI register from your monitoring plan; every KRI there must appear here with full definitions.
  2. Keep QTLs aligned to your critical-to-quality factor register and keep the count small.
  3. Wire the disposition log to your central monitoring meeting so entries are made at review, not reconstructed later.
  4. Link outcomes to your query, deviation, and CAPA systems by reference.
  5. Confirm the regulatory status of each reference before use.
Use madhadi.com as an app Full screen, works offline, one tap from your home screen.